Antibody drug discovery platform
The company has established an antibody drug discovery platform that includes bispecific antibody drug capabilities.
Source: LinkedIn company description · Retrieved October 13, 2026
Light Chain Bioscience focuses on research and development of novel multispecific antibodies that rely on their light chain for function.
Light Chain Bioscience is a brand of Novimmune SA, which focuses on bispecific technology and associated programs. The company’s pipeline includes preclinical and clinical candidates for validated and novel targets.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The company has established an antibody drug discovery platform that includes bispecific antibody drug capabilities.
Source: LinkedIn company description · Retrieved October 13, 2026
Research and development centers on novel multispecific antibodies that rely on their light chain for function.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 3, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 6, 2026, September 18, 2026, September 19, 2026, September 21, 2026, September 29, 2026 and October 7, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.